Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × Interleukin-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 60 Leukemia, Myeloid, Acute 25 Carcinoma, Renal Cell 23 Neoplasm Metastasis 16 Breast Neoplasms 16 Leukemia 15 Neuroblastoma 12 Kidney Neoplasms 12 Ovarian Neoplasms 11 Lymphoma, Non-Hodgkin 11 Carcinoma, Non-Small-Cell Lung 10 Myelodysplastic Syndromes 9 Recurrence 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Neoplasms 6 Multiple Myeloma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Fallopian Tube Neoplasms 5 Congenital Abnormalities 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Skin Neoplasms 4 Rectal Neoplasms 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Lung Neoplasms 4 Hematologic Neoplasms 4 Triple Negative Breast Neoplasms 3

Interventions

Magnetic Resonance Spectroscopy 11 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Ga(III)-DOTATOC 3 Bevacizumab 3 trametinib 2 arginyllysine 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Sodium Chloride 2 Radiotherapy 2 Protons 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Imaging 2 Imatinib Mesylate 2 Gadolinium DTPA 2 Fluorodeoxyglucose F18 2 Filgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡